Book an Appointment
Dr. Esha Kaul

Dr. Esha Kaul

Director

17 years of experience

Bone Marrow Transplant Surgeons, Hematologist, Medical Oncologists

MBBS, Fellowship

Max Multi Speciality Centre, Noida

Max Super Speciality Hospital, Vaishali, Ghaziabad

English, Hindi

Consultation Fee ₹ 1000

Book an Appointment

About Dr. Esha Kaul

  • Dr. Esha Kaul is a well-known Medical Oncologist, Hematologist, and Bone Marrow Transplant Specialist with over 17 years of experience.
  • She specializes in plasma cell disorders such as myelodysplastic syndromes, multiple myeloma, amyloidosis, and myeloproliferative disorders.
  • Her educational qualifications include an MBBS from All India Institute of Medical Sciences (AIIMS), New Delhi, 2006, and an Internship from Albert Einstein Medical Center, Philadelphia, USA, 2009
  • She further achieved a residency (Internal medicine) and a fellowship (Hematology-oncology) from Tufts University, Boston, USA, in 2011 and 2014.
  • She received multiple accolades, including the Abstract Achievement Award and Institute Book Prize, during her undergraduate studies at AIIMS.
  • Dr. Kaul is recognized for academic excellence, ranked among the top 30 students nationwide, and nominated for the Sorel Catherine Freyman Gold Medal in Pediatrics.
  • She is a member of prestigious organizations, including the American Society of Bone Marrow Transplant, International Myeloma Society, American Society of Transplant and Cellular Therapy, and American Society of Hematology.
  • Dr. Kaul is fluent in English and Hindi.

Education

  • MBBS, All India Institute of Medical Sciences (AIIMS), New Delhi, 2006
  • Internship, Albert Einstein Medical Center, Philadelphia, USA, 2009
  • Residency (Internal Medicine), Tufts University, Boston, USA, 2011
  • Fellowship (Hematology-Oncology), Tufts University, Boston USA, 2014

Past Experience

  • Junior Resident (Employee Health Services), All India Institute of Medical Sciences, New Delhi, 2007
  • Intern (Internal Medicine), Albert Einstein Medical Center, Philadelphia, PA, 2009
  • Resident (Internal Medicine), Tufts Medical Center, Boston, MA, 2011
  • Associate Consultant (Hematology- Oncology/Bone Marrow Transplant), BL Kapoor Super Speciality Hospital, New Delhi, 2016
  • Executive Consultant (Hematology- Oncology/Bone Marrow Transplant), Jaypee Hospital, Noida

Awards

  • Received Award of Excellence for being in the top 30 students in the country in the Indian National Biology Olympiad, 2001.
  • Ranked No. 1 in the All India Armed Forces Medical College Entrance Examination, 2001.
  • Received Certificate of Merit for being among the top 0.1% of successful candidates in English in All India Senior School Certificate Examination, 1999.
  • Received the Priyaneet Aujla Memorial Award for the Best All-Round Student, St. Peter's Academy, 1999.

Associations/Membership

  • American Society of Hematology
  • Indian Society of Bone Marrow Transplant
  • American Society of Transplant and Cellular Therapy
  • International Myeloma Society

Paper Published

  • Agarwal N, Pandey P, Kaul E, Dhingra N, Kumar P. Mechanical Cryopreservation of peripheral blood stem cell: Initial experience from a tertiary care hospital. Indian J Hematol Blood Transfus 2019 in print
  • Chaulagain CP, Sprague KA, Pilichowska M, Cowan J, Klein AK, Kaul E, Miller KB. Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Bone Marrow Transplant. 2019 Apr;54(4):560-566
  • Kaul E; Precision medicine in Hematological Malignancies; Pharma Times, March 2019
  • Kaul E; Platelet transfusions: When, What and How Much? Management of platelet disorders in clinical practice: UP Journal of Internal Medicine, March 2019
  • Sehgal T, Singh P, Kaul E; Stodtmeister Cells (Polymorphs with Pelger-Huët Anomaly) Showing "Faggots" in Mixed Phenotypic Acute Leukemia (T/Myeloid). Indian J Hematol Blood Transfus. 2018 Jan;34(1):148-150
  • Kaul E, Sharma SK; Multiple Myeloma; Looking beyond standards; Asian Journal of Oncology; Jan-Mar 2016; 2(1) 23-28,
  • Sharma SK, Choudhary D, Kaul E, et al. Hematopoietic Stem Cell Transplant in Elderly Patients: Experience from a Tertiary Care Centre in Northern India; Indian J Hematol Blood Transfus 2016 Jun; 32(Suppl1) 205-207.
  • Kaul E, Shah G, Chaulagain C, Comenzo R: Plerixafor and G-CSF for Autologous Stem Cell Mobilization in AL Amyloidosis; BMT; 2014 Sep;49(9):1233
  • Kaul E, Pilichowska M, Vullaganti M, Madan N, Comenzo R; Twists and Turns of Determining Amyloid Type and Amyloid-related Organ Damage: Discordance and Clinical Skepticism in the Era of Proteomic Typing. Amyloid, 2014 Mar; 21(1):62-5.
  • Shah G, Kaul E, Klein A, Miller K, Cossor F, Fallo S, Sprague K, Comenzo R: Open Label Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients with Myeloma or Systemic AL Amyloidosis: A Retrospective Chart Review of Response Rates and Toxicity; Clinical Therapeutics,2013 October;35(10) 1614-20.
  • Kaul E, Dhingra N; Successful Allogenic and Autologous Transplant with Concurrent Usage of Direct-Acting Antivirals for Hepatitis C in Children with Hematological Malignancies, accepted for publication at SIOP 2019
  • Khandelwal V, Choudhary D, Sharma S, Kharya G, Kaul E, Kothari S, Doval D, Setia R, Handoo A: Haploidentical Hematopoietic Stem Cell Transplant for Thalassaemia Major Using pre-transplant immunosuppression and Post Transplant Cyclophosphamide; Accepted for presentation at the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation; Valencia, Spain; 2016
  • Esha Kaul, Sweta Kothari, Rasika Setia, Sanjeev Sharma, Saad Suleiman, Vipin Khandelwal, Gaurav Kharya, Bharti Sharma, Anil Handoo and Dharma Choudhary: Peripheral Blood Stem Cell Collection on Day 4 Is Feasible and Safe in a Majority of Allogeneic Stem Cell Transplant Donors; ASBMT Feb 2016; Honolulu, Abstract #483
  • Esha Kaul, Sweta Kothari, Rasika Setia, Sanjeev Sharma, et al.; Day 4 Peripheral Blood Stem Cell Collection in Myeloma Patients is Feasible and Cost-effective in a Majority of Patients; Abstract presented at the 15th International Myeloma Workshop; September 2015; Rome, Italy; PO#155
  • Vyas O, Kaul E, Rosenberg A, Shah G, Shah U, Comenzo RL et al.; Splenic Irradiation and a Reduced-Intensity Conditioning Regimen Prior to Allogeneic Stem-Cell Transplantation for Myelofibrosis. Poster presentation at American Society of Hematology meeting December 2014 # 3170
  • Shah G, Kaul E, Comenzo R. High Response Rates and Minimal Toxicity with Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients Systemic AL Amyloidosis. International Symposium on Amyloidosis. 2014. Oral presentation
  • Kaul E, Shah G, Comenzo R; Plerixafor and G-CSF for Autologous Stem Cell Mobilization in AL Amyloidosis: Update of a Single Center Experience; Poster presentation at 2014 BMT Tandem Meetings # 144
  • Chaulagain C, Sprague K, Klein A, Pilichowska M, Kaul E, Miller K; Squamous Cell Cancers of Head and Neck in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation; Poster presentation at 2014 BMT Tandem Meetings
  • Shah G, Rosenberg A, Kaul E, Stevenson R, Chin J, Shah U, Dinitz A, Cossor F, Smith H, Klein A, Comenzo R, Miller K, Van Etten R, Siegel R, and Sprague K. Improvement of Blood Glucose Control on the Bone Marrow Transplant (BMT) Unit: A Retrospective Review of Our Quality Improvement Pilot Program. (ASBMT Annual Meeting Abstracts). 2013; # 306.
  • Kaul E, Flores JP, Paulus J, Gunturu K, Hematology and Oncology; Natural Allies or Time to Part Ways? Results of a Medicine Resident Survey. American Society of Hematology meeting December 2013, Poster # 2920
  • Kaul E, Shah G, Comenzo R; Plerixafor and G-CSF for Autologous Stem Cell Mobilization in AL Amyloidosis: a Single Center Experience. American Society of Hematology Meeting December 2013, Poster # 4516
  • Chaulagain C, Kaul E, Miller K; Clinicopathologic Characteristics of Secondary Non-Hematologic Malignancies in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies. Blood, October 2013, Vol 122, 5496

Field of Expertise

  • ABO Incompatible Transplant
  • Adrenal Cancer Treatment
  • Allogeneic Bone Marrow Transplant
  • Autologous Bone Marrow Transplant
  • Benign and Cancerous Tumor Excision
  • Bile Duct Cancer Treatment
  • Bone Marrow Transplant
  • Brain Tumor Surgery
  • Breast Biopsy
  • Carcinoid Tumor Treatment
  • Castleman Disease Treatment
  • Chemotherapy
  • Colon Cancer Surgery
  • Completion Thyroidectomy
  • Deceased Donor Liver Transplants (DDLTs)
  • Endometrial Cancer Treatment
  • Endoscopic Tumor Removal
  • Ewing Family of Tumors Treatment
  • Fine Needle Aspiration
  • Genitourinary Cancer Treatment
  • Gestational Trophoblastic Disease (GTD) Treatment
  • Haplo–Allogeneic Bone Marrow Transplant
  • Hematopoietic Stem Cell Transplantation (HPSCT)
  • Hormone Therapy
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Image-Guided Radiation Therapy (IGRT)
  • Immunotherapy
  • Incompatible Kidney Transplant
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Intestinal Transplant
  • Kaposi Sarcoma Treatment
  • Kidney Transplant
  • Liver Transplant
  • Living Donor Liver Transplant (LDLT)
  • Lumpectomy
  • Lung Transplant
  • Malignant Mesothelioma Treatment
  • Metastatic Tumor Treatment
  • Minimally Invasive Cancer Surgery
  • Nasal Cavity and Paranasal Sinus Cancer Treatment
  • Nasopharyngeal Cancer Treatment
  • Non-Small Cell Lung Cancer (NSCLC) Treatment
  • Oncological Surgery
  • Pancreas Transplant
  • Papillary Thyroid Cancer Treatment
  • Pediatric Bone Marrow Transplant
  • Pediatric Liver Transplant
  • Penile Cancer Treatment
  • PET CT Scan
  • Proton Therapy
  • Radiation Therapy
  • Radioisotope Therapy
  • Rhabdomyosarcoma (RMS) Treatment
  • Robotic Cancer Surgery
  • Skin Lymphoma Treatment
  • Small Intestine Cancer Treatment
  • Stem Cell Transplant
  • Targeted Therapy
  • Thymectomy
  • Thymoma and Thymic Carcinoma Treatment
  • Transarterial Chemoembolization (TACE)
  • Vaginal Cancer Treatment
  • Vulvar Cancer Treatment
  • Whipple Procedure
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia (AML)
  • Acute Promyelocytic Leukemia (APL)
  • Adenocarcinoma
  • Adenosquamous Carcinoma
  • Adrenocortical Carcinoma
  • Adult Hodgkins Lymphoma
  • AIDS-Related Cancer
  • Ameloblastoma
  • Anal Cancer
  • Anaplastic Carcinoma
  • Anemia
  • Aplastic Anemia
  • Appendix Cancer
  • Atypical Hyperplasia
  • Atypical Spindle Cell Tumor
  • Atypical Teratoid/Rhabdoid Tumor (ATRT)
  • Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
  • Basal Cell Carcinoma (BCC)
  • Basal Cell Carcinoma of the Skin
  • Benign Bone Tumors
  • Benign Hematology
  • Benign Lung Tumors
  • Benign Soft Tissue Tumors
  • Bile Duct Cancer, Stones, & Strictures
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Bone Marrow Cancer
  • Breast Cancer
  • Breast Cancer During Pregnancy
  • Breast Cancer Recurrence
  • Bronchial Tumors
  • Burkitt Lymphoma
  • Cancer in Children
  • Carcinoid Syndrome
  • Carcinoid Tumor (Gastrointestinal)
  • Carcinoid Tumors of the Lungs
  • Cervical Cancer
  • Childhood Acute Lymphoblastic Leukemia
  • Cholangiocarcinoma
  • Chronic Granulomatous Disease (CGD)
  • Chronic Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelogenous Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Chronic Myeloproliferative Neoplasms
  • Colorectal Cancer
  • Cutaneous T-Cell Lymphoma
  • Cyclic Neutropenia
  • Desmoid Tumor
  • Diamond-Blackfan Anemia (DBA)
  • Ductal Carcinoma in Situ (DCIS)
  • Dyskeratosis Congenita (DKC)
  • Elevated PSA (Prostate-Specific Antigen) Level
  • Embryonal Tumors
  • Eosinophilia
  • Eosinophilic Disorders
  • Esophageal Cancer
  • Esophagectomy
  • Essential Thrombocythemia
  • Esthesioneuroblastoma
  • Estrogen Dependent Cancers
  • Ewing Sarcoma
  • Extracranial Germ Cell Tumor
  • Extragonadal Germ Cell Tumor
  • Extrahepatic Bile Duct Cancer
  • Fallopian Tube Cancer
  • Familial Adenomatous Polyposis (FAP)
  • Familial Adenomatous Polyposis (FAP): Inherited
  • Fanconi Anemia (FA)
  • Follicular Lymphoma
  • Free Flap Surgery for Treating Osteoradionecrosis
  • Gallbladder Cancer
  • Gastric Cancer
  • Gastrointestinal Stromal Tumor (GIST)
  • Gestational Trophoblastic Disease
  • Giant Cell Tumor
  • Gum Tumor
  • Hairy Cell Leukemia (HCL)
  • Head and Neck Cancer
  • Heart Cancer
  • Hemochromatosis
  • Hemolytic Anemia
  • Hemophilia
  • Hepatocellular Cancer
  • Hereditary Non-polyposis Colorectal Cancer (HNPCC)
  • Hereditary Spherocytosis
  • Hodgkin Lymphoma
  • Hurthle Cell Carcinoma
  • Hypopharyngeal Cancer
  • Hypopharyngeal Cancer
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Immunotherapy
  • In-situ Breast Cancer
  • Incontinence After Prostate Surgery
  • Inflammatory Breast Cancer
  • Inherited Bone Marrow Failure Syndromes (IBMFS)
  • Intensity Modulated Radiation Therapy
  • Intraocular Melanoma
  • Invasive Breast Cancer
  • Invasive Lobular Carcinoma
  • Iron-Deficiency Anemia
  • Islet Cell Tumor
  • Kaposi Sarcoma
  • Langerhans Cell Histiocytosis (LHC)
  • Large Cell Carcinoma
  • Large Granular Lymphocytic (LGL) leukemia
  • Leukemia
  • Leukopenia
  • Lip and Oral Cavity Cancer
  • Liver Cancer
  • Liver Cysts & Liver Tumors
  • Lung Cancer
  • Lymphatic Cancer
  • Lymphocytosis
  • Male Breast Cancer
  • Malignant Fibrous Histiocytoma (MFH)
  • Malignant Mesothelioma
  • Malignant Soft Tissue Tumors
  • Mastocytosis
  • Mediastinal Tumor
  • Medullary Carcinoma
  • Melanoma
  • Merkel Cell Carcinoma
  • Metastatic Cancer
  • Metastatic Spinal Tumors
  • Metastatic Squamous Neck Cancer with Occult Primary
  • Metastatic Tumors
  • Monoclonal Gammopathy
  • Mouth Cancer
  • Multiple Endocrine Neoplasia (MEN) Syndromes
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Myelodysplastic Syndromes (MDS)
  • Myelofibrosis
  • Myeloproliferative Neoplasms (MPN)
  • Nasal Cavity and Paranasal Sinus Cancer
  • Nasopharyngeal Cancer
  • Neuroendocrine Tumor
  • Non-Hodgkin Lymphoma
  • Non-Small Cell Lung Cancer
  • NUT Midline Carcinoma
  • Oncogenic Osteomalacia
  • Ophthalmic Cancer
  • Oral Cancer
  • Oropharyngeal Cancer
  • Osteosarcoma
  • Ovarian Cancer
  • Ovarian Germ Cell Tumors
  • Ovarian Primary Peritoneal Cancer
  • Ovarian Sex Cord Stromal Tumor
  • Pancreatic Cancer
  • Pancreatic Neuroendocrine Tumor
  • Paraganglioma
  • Paraneoplastic Syndromes
  • Parathyroid Cancer
  • Parotid Gland Tumor
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric Chordomas
  • Pediatric Ependymoma
  • Pediatric Germ Cell Tumor
  • Pediatric Rhabdomyosarcoma
  • Pediatric Spinal Cord Tumor
  • Pediatric Spinal Tumor
  • Pediatric Vascular Tumors
  • Penile Cancer
  • Pernicious Anemia
  • Pharyngeal Cancer
  • Pheochromocytoma
  • Pigmented Villonodular Synovitis (PVNS)
  • Pineal Region Tumor
  • Plasma Cell Neoplasms
  • Pleural Tumor
  • Pleuropulmonary Blastoma
  • Polycythemia Vera
  • Porphyria
  • Post-Transplant Lymphoproliferative Disorder (PTLD)
  • Prostate Cancer
  • PTEN Hamartoma Tumor Syndrome (Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome)
  • Pulmonary Nodules
  • Pure Red Cell Aplasia (PRCA)
  • Rectal Cancer
  • Recurrent Cancer
  • Relapsed ALL
  • Relapsed AML
  • Relapsed Multiple Myeloma
  • Renal Cell Cancer
  • Retinoblastoma (Cancer of the Eye)
  • Retroperitoneal Tumor
  • Rhabdomyosarcoma
  • Salivary Gland Cancer
  • Sarcoma
  • Sezary Syndrome
  • Shwachman-Diamond syndrome (SDS)
  • Sickle Cell Anemia
  • Skin Cancer
  • Skull Base Tumor
  • Small Cell Carcinoma
  • Small Cell Lung Cancer
  • Small Intestine Cancer
  • Soft Tissue Sarcoma
  • Spinal Tumor
  • Squamous Cell Carcinoma (SCC)
  • Stage 4 Cancer
  • Stomach Cancer
  • Sun Exposure & Skin Cancer
  • Synovial Sarcoma
  • Testicular Cancer
  • Thalassemia
  • Throat Cancer
  • Thrombocytopenia
  • Thrombocytosis
  • Thrombophilia
  • Thrombotic Thrombocytopenic Purpura (TTP)
  • Thymoma and Thymic Carcinoma
  • Thymus Gland Tumor
  • Thyroid Cancer
  • Tracheobronchial Tumor
  • Transitional Cell Cancer
  • Urethral Cancer
  • Uterine Sarcoma
  • Vaginal Cancer
  • Vascular Tumor
  • Venous Thromboembolism (VTE)
  • Von Willebrand Disease
  • Vulvar Cancer
  • Waldenstrom Macroglobulinemia
  • Wilms Tumor
View All

Now Request Doctor Appointment in Easy Steps

Best Oncology Doctors in India

View All
View All
Enquiry Now